KKR (KKR) has become Morgan Stanley's top pick instead of CME Group (CME) amid improving macroeconomic conditions and normalizing volatility, Morgan Stanley said in a note e-mailed Thursday.
"A capital markets rebound that's back on track is set to reaccelerate the private markets flywheel, supporting a robust earnings outlook for KKR," the brokerage said in a note to clients.
The private-equity giant's diversity across end markets is best placed to take advantage of "secular tailwinds" across private credit, infrastructure, private wealth, and insurance that back an outlook for a double-digit growth, Morgan Stanley said.
"We still see CME as a defensive beneficiary of uncertainty that may persist, but macro conditions have trended better than feared and volatility has since normalized from early 2Q levels," the brokerage said.
Morgan Stanley reiterated its overweight rating on the KKR stock, with a $150 price target.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。